Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 17 May 2024 04:09:30 +0200Wed, 15 May 2024 15:36:00 +0200Xevudy : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5676-en_2.pdfXevudy : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5676-en_2.pdfWed, 15 May 2024 15:36:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 15, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xevudyHuman medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 15, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xevudyFri, 26 Apr 2024 15:39:00 +0200Human medicine